Back to Search Start Over

Outcome of Relapsed DLBCL Patients, Treated with Polatuzumab-BR or Polatuzumab-R: Real Life Data

Authors :
Segman, Yafit
Ribakovsky, Elena
Avigdor, Abraham
Vainstein, Vladimir
Goldschmidt, Neta
Harlev, Shimrit Ringelstein
Gutwein, Odit
Abadi, Uri
Nemets, Anatoly
Sofer, Orit
Dally, Najib
Filanovsky, Kalman
Leiba, Merav
Sarid, Nadav
Benyamini, Noam
Herishanu, Yair
Ram, Ron
Perry, Chava
Avivi, Irit
Source :
Blood; November 2019, Vol. 134 Issue: Supplement 1 p5321-5321, 1p
Publication Year :
2019

Abstract

Herishanu: Roche: Honoraria; AbbVie: Honoraria; Janssen: Honoraria.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
134
Issue :
Supplement 1
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs53606397
Full Text :
https://doi.org/10.1182/blood-2019-124164